Europe


The Dollar Stopped Dropping. It Still Has a Perilous Path.

As long as the U.S. embraces tariffs, the dollar is likely to be under pressure.

2 minute read

Go to article

LVMH Gets a Downgrade From HSBC. ‘Macro Stars Are Misaligned.’

In a matter of just a few months, the mood among consumers of all incomes has turned from “treat yo’self” to “tread carefully.”

3 minute read

Go to article

Nokia Stock Drops. Trump Tariffs Will Hit Earnings, CEO Says.

Finnish telecom firm Nokia reported a disappointing first quarter, and sees tariffs hurting second-quarter operating earnings by up to 30 million euros.

2 minute read

Go to article

Apple and Meta Are Hit With EU Fines. Why That Could Provoke Trump.

Apple received a 500 million euros ($571.3 million) penalty on Wednesday while Facebook-owner Meta was fined €200 million, both for breaches of the EU’s Digital Markets Act.

3 minute read

Go to article

IMF Says Global Debt Load Crossed $100 Trillion Last Year—and Could Keep Climbing. What’s at Stake.

The global debt situation is raising alarms for the International Monetary Fund.

3 minute read

Go to article

SAP Stock Soars After Company Reiterates Guidance. CFO Says Economic Backdrop Is ‘Anything But Easy.’

The German software company’s first-quarter numbers exceeded analysts' expectations.

2 minute read

Go to article

BP Stock Jumps. Activist Elliott Raises Stake Above This Key Level.

The interest puts CEO Murray Auchincloss under pressure to deliver better results quickly.

2 minute read

Go to article

Is Your International Fund a U.S. Fund in Disguise? Why It Matters.

There’s a difference in the types of funds that invest overseas. Make sure you know what you’re getting into.

3 minute read

Go to article

Pope Francis Pushed ESG. How the Church’s Investments Did.

The Catholic Church, under the late Pope Francis, said in 2022 that ESG investing is consistent with the Church’s values.

2 minute read

Go to article

Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing

Eli Lilly plans to make its experimental drug orforglipron in the U.S. after it secures regulatory approval, says CEO Dave Ricks.

2 minute read

Go to article
BREAKING

ECB Cuts Rates Again. Why It’s Fueling Trump’s Anger at Fed’s Powell.

The European Central Bank reduced its benchmark lending rate for the seventh time since it started lowering borrowing costs in June.

2 minute read

Go to article

Trump Thinks Energy Exports Can Fix the Trade Gap. The Math Doesn’t Work.

Energy can’t do as much to close the trade gap as Trump hopes.

3 minute read

Go to article

Trump Halts Work on Major Offshore Wind Project

More than 1,500 employees already are working on the project, says its owner.

2 minute read

Go to article

ASML Stock Drops. Its Earnings Are a Look at Tariffs’ Hit on Chips.

The chip-making equipment company is feeling the pressure of the U.S. trade war.

2 minute read

Go to article

Was the European Union Created to ‘Screw the U.S.’ on Trade? Au Contraire.

President Donald Trump’s complaints about the EU overlook America’s role in the union’s history, Benn Steil writes in a guest commentary.

4 minute read

Go to article

LVMH Sales Fall as Uncertainty Crimps Luxury Demand

The world’s biggest conglomerate of luxury goods reported a 2% sales decline for its first quarter.

1 minute read

Go to article

U.S. Stocks Are No Longer a Buy, Citi Says. Where to Invest Instead.

Earnings downgrades are likely and ‘trading conditions could remain choppy’ in U.S. equities, the bank’s strategists say in a research note.

1 minute read

Go to article

Novo Remade Denmark. The Danes Are Still Adjusting.

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from science to geopolitics. 

Long Read

Go to article

Wall Street Pulls Back on the Weight-Loss Drug Hype

Goldman Sachs says the growth potential for the overall obesity market is actually getting worse.

Long Read

Go to article

This Pharma Giant Will Invest $23 Billion in the U.S. It’s a Sign Trump’s Tariffs Are Working.

The Company spend billions to produce 100% of its key medicines for Americans in the U.S.

1 minute read

Go to article

China Calls Trump Tariffs Standoff a Joke. Tesla, Apple, Stock Markets Aren’t Laughing.

Consumer prices cool but threats loom, Logitech is the latest company to pull guidance amid trade uncertainty, more news to start your day.

Long Read

Go to article

Trump Can’t Beat the Bond Market. Why He Must Conquer China on Tariffs.

The Fed worries trade war could bring persistent inflation, home buyers grabbed at a fleeting dip in mortgage rates, and more news to start your day.

Long Read

Go to article

Trump Considers More Farm Aid. It Might Not Be Enough.

Any aid package might largely benefit larger farms and leave many smaller players in the lurch as happened during the 2018 trade war.

Long Read

Go to article

Apple, Nvidia, Broadcom, Humana, CVS, Tesla, Super Micro, Marvell, and More Stock Market Movers

Apple stock rises after a three-day stretch that has seen shares of the iPhone maker tumble 19%, Broadcom announces a new buyback program of $10 billion, and Humana, CVS Health, and UnitedHealth jump as Medicare boosts payment rates.

3 minute read

Go to article

Trump Tariff Talks Give Stock Market Hope. What It Needs to Bounce Back.

Nippon Steel’s deal for U.S. Steel could be revived, MicroStrategy has an unrealized Bitcoin loss, and more news to start your day.

Long Read

Go to article

of 15 pages